Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma. (Record no. 28411817)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02360 a2200697 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517215525.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201807s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1533-4406 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1056/NEJMoa1804093 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Rabe, Klaus F |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20180705 |
245 00 - TITLE STATEMENT | |
Title | Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | The New England journal of medicine |
Date of publication, distribution, etc. | 06 2018 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 2475-2485 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Administration, Oral |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adolescent |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anti-Asthmatic Agents |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Monoclonal |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Asthma |
General subdivision | classification |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Child |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Double-Blind Method |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Therapy, Combination |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Eosinophilia |
General subdivision | chemically induced |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Forced Expiratory Volume |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Glucocorticoids |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Injections, Subcutaneous |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Intention to Treat Analysis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Logistic Models |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Receptors, Interleukin-4 |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Young Adult |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nair, Parameswaran |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Brusselle, Guy |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Maspero, Jorge F |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Castro, Mario |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sher, Lawrence |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zhu, Hongjie |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hamilton, Jennifer D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Swanson, Brian N |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Khan, Asif |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chao, Jingdong |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Staudinger, Heribert |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pirozzi, Gianluca |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Antoni, Christian |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Amin, Nikhil |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ruddy, Marcella |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Akinlade, Bolanle |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Graham, Neil M H |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Stahl, Neil |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Yancopoulos, George D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Teper, Ariel |
773 0# - HOST ITEM ENTRY | |
Title | The New England journal of medicine |
Related parts | vol. 378 |
-- | no. 26 |
-- | p. 2475-2485 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1056/NEJMoa1804093">https://doi.org/10.1056/NEJMoa1804093</a> |
Public note | Available from publisher's website |
No items available.